Krystal Biotech, Inc. (KRYS) — 10-Q Filings
All 10-Q filings from Krystal Biotech, Inc.. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
- 10-Q Filing — May 4, 2026
-
Krystal Biotech's VYJUVEK Sales Drive 41% Revenue Surge
— Nov 3, 2025 Risk: low
Krystal Biotech, Inc. reported robust financial performance for the three and nine months ended September 30, 2025, driven by strong VYJUVEK sales. Product reve -
Krystal Biotech's Revenue Soars, Net Loss Narrows on Product Launch
— Aug 4, 2025 Risk: medium
Krystal Biotech, Inc. reported a significant increase in product revenue for the three months ended June 30, 2025, reaching $55.2 million, up from $0 in the pri -
Krystal Biotech Files Q1 2025 10-Q Report
— May 6, 2025 Risk: medium
Krystal Biotech, Inc. filed its quarterly report for the period ending March 31, 2025. The company, based in Pittsburgh, PA, is involved in the biological produ -
Krystal Biotech Files Q3 2024 10-Q
— Nov 4, 2024 Risk: medium
Krystal Biotech, Inc. filed its 10-Q for the period ending September 30, 2024. The company is involved in the development of biological products. Specific finan -
Krystal Biotech Files Q2 2024 10-Q
— Aug 5, 2024 Risk: medium
Krystal Biotech, Inc. filed its 10-Q for the period ending June 30, 2024. The company, focused on biological products, reported financial results for the second -
Krystal Biotech, Inc. Files 10-Q for Period Ending March 31, 2024
— May 6, 2024 Risk: low
Krystal Biotech, Inc. (KRYS) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. Krystal Biotech, Inc. filed a 10-Q report for the period ending March
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX